However, in this study, we could not observe a fully therapeutic effect on the kidney or the heart since the different pathophysiological mechanisms in CKD likely remain active (e.g., activation of the renin–angiotensin–aldosterone system, uremia, dyslipidemia, proteinuria, fibrosis and secretion of growth factors and cytokines, among others). Here, REN is linked to metabolic syndrome.